Elevance Health, Inc. (ELV) — Institutional Holders, Q2 2026 (page 17)

1,617 institutional investment managers reported a ELV position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $76.7B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1,601 to 1,617. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ELV 13F holders ranked 1,601–1,617 of 1,617

Institutional investors reporting a position in Elevance Health, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
N.E.W. Advisory Services#1601 · 2 sh$773.00-93.8%
Rakuten Securities#1602 · 2 sh$773.00+100.0%
Meramec Financial Planners#1603 · 2 sh$757.000.0%
SOA Wealth Advisors#1604 · 1 sh$414.00-50.0%
Frazier Financial Advisors#1605 · 1 sh$403.000.0%
MARYLAND CAPITAL ADVISORS#1606 · 1 sh$387.00—
Glass Jacobson Investment Advisors#1607 · 1 sh$387.000.0%
Cherry Tree Wealth Management#1608 · 1 sh$387.000.0%
EVOLUTION WEALTH MANAGEMENT#1609 · 1 sh$387.000.0%
Cordant#1610 · 1 sh$338.00New
Darwin Wealth Management#1611 · 0 sh$305.00New
Halbert, Hargrove/Russell#1612 · 0 sh$151.00New
Copia Wealth Management#1613 · 0 sh$25.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#1614 · 320,688 sh—-3.1%
VESTOR CAPITAL#1615 · 239 sh—-85.5%
Elequin Securities#1616 · 189 sh—New
Quantum Portfolio Management#1617 · 496 sh—New

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.